Top stories in endocrinology: Most adults with diabetes, CVD do not meet secondary prevention targets; pioglitazone may benefit ‘diabetic lung disease’

Of the top stories in endocrinology, four are from the Heart in Diabetes 2018 meeting.

Less than one-third of adults with diabetes and CVD achieve goals for secondary prevention, according to one presenter at the meeting. Another presenter showed that pioglitazone may serve as a tool to prevent or delay pulmonary arterial hypertension, which is a growing problem in the setting of insulin resistance and type 2 diabetes.

Also, another speaker noted that traditional risk factor modification is a top priority in patients with diabetes and CVD. The debate over the optimal target for BP management in type 2 diabetes with comorbid hypertension was touched on by two speakers.

Lastly among the top stories was a study demonstrating that delayed bottle-feeding and longer duration of breastfeeding may confer protection against obesity at age 6 years. – by Jake Scott

Most adults with diabetes, CVD do not meet secondary prevention targets

Less than one-third of adults with diabetes and CVD achieve goals for secondary prevention, including smoking cessation, use of prophylactic medications, and blood pressure and lipid control, according to a speaker at Heart in Diabetes. Read More.

In emerging area of ‘diabetic lung disease,’ pioglitazone may play preventive role

Pulmonary arterial hypertension is a growing problem in the setting of insulin resistance and type 2 diabetes, and pioglitazone may serve as a tool to prevent or delay the disease course, according to a speaker at Heart in Diabetes. Read More.

In diabetes with CVD, traditional risk factor modification remains top priority

Studies demonstrating the dual efficacy of antihyperglycemic agents on both glucose and CVD risk should change the treatment landscape only in people with high CV risk or established disease, according to a speaker at Heart in Diabetes. Read More.

Delay in bottle-feeding may reduce early childhood obesity risk

Among children whose introduction to bottle-feeding is delayed, the longer duration of breastfeeding may confer protection against obesity at age 6 years, according to a study published in Childhood Obesity. Read More.

Consider patient risk when targeting BP in diabetes

A debate continues over the optimal target for BP management in type 2 diabetes with comorbid hypertension, with some experts pushing for a lower goal whenever possible, whereas others prefer a more individualized, patient-centered approach, according to two speakers at Heart in Diabetes. Read More.